I-Rivaroxaban CAS: 366789-02-8 Umthengisi woMvelisi

I-Rivaroxaban yiarhente entsha yokulwa noxinzelelo lwegazi. Yinto entsha, esetyenziswa ngomlomo, nekhethwayo yokuthintela ngokuthe ngqo i-factor Xa eyenziwe yiBayer Healthcare. Ivunyiwe yi-EMEA kunye ne-FDA ukuthintela i-venous thromboembolism kwizigulana ezindala emva kokutshintshwa kwesinqe ngokupheleleyo okanye utyando lokufakelwa idolo ngokupheleleyo.

Oda okanye Cela iKoteshini

Iinkcukacha zeMveliso

Iithegi zeMveliso

Ukusetyenziswa kunye nesiphumo

I-Rivaroxaban ineempawu zokuba ne-bioavailability ephezulu, uluhlu olubanzi lwezifo ekujoliswe kuzo, ubudlelwane obuzinzileyo phakathi kwedosi kunye nesiphumo, kulula ukuyithatha ngomlomo, kunye nomngcipheko ophantsi wokopha. I-Rivaroxaban inokuthintela kwaye inyange i-venous thrombosis. Isetyenziswa kakhulu kwiklinikhi ukuthintela i-deep venous thrombosis (DVT) kunye ne-pulmonary embolism (PE) kwizigulana ezindala emva kotyando lokutshintshwa kwe-hip kunye nedolo. Ikwasetyenziselwa ukuthintela izigulana ezine-nonvalvular atrial fibrillation kwi-cerebral apoplexy kunye ne-noncentral nervous system embolism, kwaye inokunciphisa umngcipheko wokuphinda ubuye kwe-coronary syndromes.

Isampuli yeMveliso

Ukupakisha imveliso:

Iinkcukacha ezongezelelweyo:

Ukwakhiwa	C19H18ClN3O5S
Uvavanyo	99%
Inkangeleko	Umgubo omhlophe
Inombolo ye-CAS	366789-02-8
Ukupakisha	25KG
Beka ubomi kwishelufa	iminyaka eyi-2
Indawo yokugcina izinto	Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso	I-ISO.